Celldex Therapeutics
CLDX
$36.30
Share price
0.11%
Change (1 day)
14.40%
Change (1 year)
Categories
Celldex Therapeutics (CLDX) Fails to deliver data
Key failure to deliver metrics for Celldex Therapeutics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.23 M
- Last 3 months FTD volume: $0.8 M
- Last year FTD volume: $3.83 M
Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019
Volume in USD (price x number of shares), data since 2019Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.76 M | -80.54% |
| 2023 | $3.94 M | -85.8% |
| 2022 | $27.79 M | -36.31% |
| 2021 | $43.63 M | 146.97% |
| 2020 | $17.66 M | 1075.04% |
| 2019 | $1.5 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | $0.02 M | $0.13 M | 🇺🇸 USA |
 Seagen
SGEN | N/A | $38.78 M | 🇺🇸 USA |
 Agenus
AGEN | $3.33 M | $6.35 M | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.74 M | $6.58 M | 🇺🇸 USA |